For: | Däbritz J, Musci J, Foell D. Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol 2014; 20(2): 363-375 [PMID: 24574706 DOI: 10.3748/wjg.v20.i2.363] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i2/363.htm |
Number | Citing Articles |
1 |
Elena A. Usacheva, Jian-P. Jin, Lance R. Peterson. Host response to Clostridium difficile infection: Diagnostics and detection. Journal of Global Antimicrobial Resistance 2016; 7: 93 doi: 10.1016/j.jgar.2016.08.002
|
2 |
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. Consenso mexicano sobre el síndrome de intestino irritable. Revista de Gastroenterología de México 2016; 81(3): 149 doi: 10.1016/j.rgmx.2016.01.004
|
3 |
Pengpeng Xia, Xin Ma, Li Yan, Siqi Lian, Xiangyu Li, Yi Luo, Ziyue Chen, Xingduo Ji. Generation and Application of Monoclonal Antibodies against Porcine S100A8, S100A9, and S100A12 Proteins Using Hybridoma Technology. International Journal of Molecular Sciences 2024; 25(2): 1029 doi: 10.3390/ijms25021029
|
4 |
Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Ockenga, Claudia Ott, Britta Siegmund, Sebastian Zeißig, Andreas Stallmach. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Zeitschrift für Gastroenterologie 2022; 60(03): 332 doi: 10.1055/a-1713-3941
|
5 |
Pengpeng Xia, Xingduo Ji, Li Yan, Siqi Lian, Ziyue Chen, Yi Luo. Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity. Immunology 2024; 171(3): 365 doi: 10.1111/imm.13722
|
6 |
Ishita Mostafa, Rahvia Alam Sthity, Umme Habiba Lamiya, Md. Tariqujjaman, Mustafa Mahfuz, S. M. Tafsir Hasan, Tahmeed Ahmed. Effect of Gut Microbiota-Directed Complementary Food Supplementation on Fecal and Plasma Biomarkers of Gut Health and Environmental Enteric Dysfunction in Slum-Dwelling Children with Moderate Acute Malnutrition. Children 2024; 11(1): 69 doi: 10.3390/children11010069
|
7 |
Reza Ranjbar, Mohamad Ghasemian, Mahmood Maniati, Seyyed Hossein Khatami, Navid Jamali, Mortaza Taheri-Anganeh. Gastrointestinal disorder biomarkers. Clinica Chimica Acta 2022; 530: 13 doi: 10.1016/j.cca.2022.02.013
|
8 |
S Ho, K Woodford, S Kukuljan, S Pal. Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot study. European Journal of Clinical Nutrition 2014; 68(9): 994 doi: 10.1038/ejcn.2014.127
|
9 |
T. Sagawa, S. Kakizaki, T. Tomizawa, T. Nakayama, H. Tanaka, H. Tojima, K. Sato, M. Kusano, S. Okamura, M. Yamada. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy. Colorectal Disease 2016; 18(7): 696 doi: 10.1111/codi.13258
|
10 |
Christian Syukur, Bradley Jimmy Waleleng, Fandy Gosal, Luciana Sophie Mariana Rotty, Jeanne Winarta, Andrew Waleleng. Tumor Necrosis Factor-α, Fecal Calprotectin, and Disease Activity in Inflammatory Bowel Disease Patients. Open Access Macedonian Journal of Medical Sciences 2023; 11(B): 346 doi: 10.3889/oamjms.2023.11284
|
11 |
Nicholas J Talley. Evolution of the Diagnosis of Functional Gut Disorders: Is an Objective Positive Diagnostic Approach Within Reach?. Clinical and Translational Gastroenterology 2015; 6(7): e104 doi: 10.1038/ctg.2015.29
|
12 |
Dandan Liu, Varma Saikam, Katie A. Skrada, Didier Merlin, Suri S. Iyer. Inflammatory bowel disease biomarkers. Medicinal Research Reviews 2022; 42(5): 1856 doi: 10.1002/med.21893
|
13 |
Byung Chang Kim, Jungnam Joo, Hee Jin Chang, Hyun Yang Yeo, Byong Chul Yoo, Boram Park, Ji Won Park, Dae Kyung Sohn, Chang Won Hong, Kyung Su Han, John Souglakos. A Predictive Model Combining Fecal Calgranulin B and Fecal Occult Blood Tests Can Improve the Diagnosis of Colorectal Cancer. PLoS ONE 2014; 9(9): e106182 doi: 10.1371/journal.pone.0106182
|
14 |
Carlos Teruel, Elena Garrido, Francisco Mesonero. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 78-90 doi: 10.4292/wjgpt.v7.i1.78
|
15 |
Maxime M.W. De Sloovere, Dieter De Smet, Filip J. Baert, Johan Debrabandere, Hilde J.M. Vanpoucke. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease. Clinical Chemistry and Laboratory Medicine (CCLM) 2017; 55(9) doi: 10.1515/cclm-2016-0796
|
16 |
Magdy El-Salhy. Recent advances in the diagnosis of irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2015; 9(9): 1161 doi: 10.1586/17474124.2015.1067138
|
17 |
Mariana del Rocio Ruiz-Briseño, Judith Carolina De Arcos-Jiménez, Sarah Ratkovich-González, Karina Sánchez-Reyes, Luz A. González-Hernández, Jaime F. Andrade-Villanueva, Monserrat Alvarez-Zavala. Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV+ patients on ART. Journal of Inflammation 2020; 17(1) doi: 10.1186/s12950-020-00262-4
|
18 |
Qihong Yu, Xinru Liu, Haojie Huang, Xingfeng Zheng, Xue Pan, Junwei Fang, Liyuan Meng, Chunhua Zhou, Xiaocui Zhang, Zhaoshen Li, Duowu Zou. Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819886425
|
19 |
Ahmed M I Elfiky, Mohammed Ghiboub, Andrew Y F Li Yim, Ishtu L Hageman, Jan Verhoeff, Manon de Krijger, Patricia H P van Hamersveld, Olaf Welting, Iris Admiraal, Shafaque Rahman, Juan J Garcia-Vallejo, Manon E Wildenberg, Laura Tomlinson, Richard Gregory, Inmaculada Rioja, Rab K Prinjha, Rebecca C Furze, Huw D Lewis, Palwinder K Mander, Sigrid E M Heinsbroek, Matthew J Bell, Wouter J de Jonge. Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(4): 668 doi: 10.1093/ecco-jcc/jjab176
|
20 |
Shiro Nakamura, Hirotsugu Imaeda, Hiroki Nishikawa, Masaki Iimuro, Minoru Matsuura, Hideo Oka, Junsuke Oku, Takako Miyazaki, Hirohito Honda, Kenji Watanabe, Hiroshi Nakase, Akira Andoh. Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study. Intestinal Research 2018; 16(4): 554 doi: 10.5217/ir.2018.00027
|
21 |
M. Camilleri, A. Shin, I. Busciglio, P. Carlson, A. Acosta, A. E. Bharucha, D. Burton, J. Lamsam, A. Lueke, L. J. Donato, A. R. Zinsmeister. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterology & Motility 2014; 26(12): 1677 doi: 10.1111/nmo.12421
|
22 |
Rebecca K. Campbell, Kerry J. Schulze, Saijuddin Shaikh, Rubhana Raqib, Lee S. F. Wu, Hasmot Ali, Sucheta Mehra, Keith P. West, Parul Christian. Environmental enteric dysfunction and systemic inflammation predict reduced weight but not length gain in rural Bangladeshi children. British Journal of Nutrition 2018; 119(4): 407 doi: 10.1017/S0007114517003683
|
23 |
Jan Däbritz, Patrick Gerner, Axel Enninger, Martin Claßen, Michael Radke. Inflammatory Bowel Disease in Childhood and Adolescence. Deutsches Ärzteblatt international 2017; doi: 10.3238/arztebl.2017.0331
|
24 |
Jason Orlando Dimitri Musci, Jack Stephen Cornish, Jan Däbritz. Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases. Journal of Gastroenterology 2016; 51(6): 531 doi: 10.1007/s00535-016-1191-3
|
25 |
Mark D. Gonzalez, Craig B. Wilen, Carey-Ann D. Burnham. Markers of Intestinal Inflammation for the Diagnosis of Infectious Gastroenteritis. Clinics in Laboratory Medicine 2015; 35(2): 333 doi: 10.1016/j.cll.2015.02.001
|
26 |
Saranya Kittanakom, Md. Sharif Shajib, Kristine Garvie, Joceline Turner, Dan Brooks, Sufian Odeh, Robert Issenman, V. Tony Chetty, Joseph Macri, Waliul I. Khan. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/1450970
|
27 |
Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignass, Robert Ehehalt, Christoph-Thomas Germer, P. C. Grunert, Ulf Helwig, Karoline Horisberger, Klaus Herrlinger, Peter Kienle, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Ockenga, Claudia Ott, Britta Siegmund, Sebastian Zeißig, Andreas Stallmach. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline. Zeitschrift für Gastroenterologie 2024; 62(08): 1229 doi: 10.1055/a-2309-6123
|
28 |
Mohammed Amin Mohammed, Alaa Mahamad A. Hakeem , Nesreen Moustafa Omar, Abdelhadi M. Shebl, Amany H. Mansour, Sherin Mohamed Abd El-Azi, Gamal Othman, Soad Amin Mohammed. Faecal Calgranulin C Versus Faecal Calprotectin as Non Invasive Markers Distinguishing Functional From Organic Causes of Chronic Diarrhea. Journal of Medical Sciences 2014; 14(4): 179 doi: 10.3923/jms.2014.179.191
|
29 |
Mohsen Hanifeh, Minna Marjaana Rajamäki, Pernilla Syrjä, Laura Mäkitalo, Susanne Kilpinen, Thomas Spillmann. Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathies. Acta Veterinaria Scandinavica 2018; 60(1) doi: 10.1186/s13028-018-0371-y
|
30 |
Catherine Colman, Marlene Stone, Alain Bitton. Inflammatory Bowel Disease Nursing Manual. 2019; : 43 doi: 10.1007/978-3-319-75022-4_6
|
31 |
James P. Campbell, Claudia Zierold, Ashli M. Rode, Frank A. Blocki, Byron P. Vaughn. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2021; 55(3): 239 doi: 10.1097/MCG.0000000000001359
|
32 |
Athanasios Tsigaridas, Ioannis S. Papanikolaou, Anna Vaiopoulou, Athanasios K. Anagnostopoulos, Nikos Viazis, George Karamanolis, Dimitrios G. Karamanolis, George T. Tsangaris, Gerasimos J. Mantzaris, Maria Gazouli. Proteomics and irritable bowel syndrome. Expert Review of Proteomics 2017; 14(5): 461 doi: 10.1080/14789450.2017.1317600
|
33 |
Marisol Garzón, Luis Pereira-da-Silva, Jorge Seixas, Ana Luísa Papoila, Marta Alves, Filipa Ferreira, Ana Reis. Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island. Pathogens and Global Health 2017; 111(3): 116 doi: 10.1080/20477724.2017.1299831
|
34 |
Marek Waluga. A Comprehensive Overview of Irritable Bowel Syndrome. 2020; : 107 doi: 10.1016/B978-0-12-821324-7.00009-5
|
35 |
Rebecca K. Campbell, Kerry J. Schulze, Saijuddin Shaikh, Sucheta Mehra, Hasmot Ali, Lee Wu, Rubhana Raqib, Sarah Baker, Alain Labrique, Keith P. West, Parul Christian. Biomarkers of Environmental Enteric Dysfunction Among Children in Rural Bangladesh. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(1): 40 doi: 10.1097/MPG.0000000000001557
|
36 |
Anke Heida, Anneke C. Muller Kobold, Lucie Wagenmakers, Koos van de Belt, Patrick F. van Rheenen. Reference values of fecal calgranulin C (S100A12) in school aged children and adolescents. Clinical Chemistry and Laboratory Medicine (CCLM) 2017; 56(1): 126 doi: 10.1515/cclm-2017-0152
|
37 |
Paul A. S. Olsen, Reidar Fossmark, Gunnar Qvigstad. Fecal calprotectin in patients with suspected small bowel disease – a selection tool for small bowel capsule endoscopy?. Scandinavian Journal of Gastroenterology 2015; 50(3): 272 doi: 10.3109/00365521.2014.1003395
|
38 |
Sanja Dragasevic, Biljana Stankovic, Nikola Kotur, Aleksandra Sokic Milutinovic, Tamara Milovanovic, Milica Stojkovic Lalosevic, Maja Stojanovic, Sonja Pavlovic, Dragan Popovic. Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease. Life 2022; 12(10): 1623 doi: 10.3390/life12101623
|
39 |
Shah Mohammad Fahim, Subhasish Das, Md. Amran Gazi, Mustafa Mahfuz, Tahmeed Ahmed. Association of intestinal pathogens with faecal markers of environmental enteric dysfunction among slum‐dwelling children in the first 2 years of life in Bangladesh. Tropical Medicine & International Health 2018; 23(11): 1242 doi: 10.1111/tmi.13141
|
40 |
Prokopis Konstanti, Marloes van Splunter, Erik van den Brink, Clara Belzer, Arjen Nauta, R. van Neerven, Hauke Smidt. The Effect of Nutritional Intervention with Lactoferrin, Galactooligosacharides and Vitamin D on the Gut Microbiota Composition of Healthy Elderly Women. Nutrients 2022; 14(12): 2468 doi: 10.3390/nu14122468
|
41 |
Ewa Skarżyńska, Joanna Żytyńska-Daniluk, Barbara Lisowska-Myjak. Meconium lactoferrin levels in neonates: can we predefine normal values?. The Journal of Maternal-Fetal & Neonatal Medicine 2017; 30(3): 279 doi: 10.3109/14767058.2016.1171307
|
42 |
Mark C. Anderson, Thibault Chaze, Yves-Marie Coïc, Louise Injarabian, Friederike Jonsson, Naelle Lombion, Dorothée Selimoglu-Buet, Judith Souphron, Caroline Ridley, Pascale Vonaesch, Bruno Baron, Ellen T. Arena, Jean-Yves Tinevez, Giulia Nigro, Katharina Nothelfer, Eric Solary, Valérie Lapierre, Thierry Lazure, Mariette Matondo, David Thornton, Philippe J. Sansonetti, Françoise Baleux, Benoit S. Marteyn. MUB40 Binds to Lactoferrin and Stands as a Specific Neutrophil Marker. Cell Chemical Biology 2018; 25(4): 483 doi: 10.1016/j.chembiol.2018.01.014
|
43 |
Qing Xiao, Fengting Yu, Liting Yan, Hongxin Zhao, Fujie Zhang. Alterations in circulating markers in HIV/AIDS patients with poor immune reconstitution: Novel insights from microbial translocation and innate immunity. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1026070
|
44 |
Taojun He, Samuel E. Kaplan, Luz A. Gomez, Xuedong Lu, Lakshmi V. Ramanathan, Mini Kamboj, Yi-Wei Tang. Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection. European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(12): 2341 doi: 10.1007/s10096-018-3381-9
|
45 |
Dorota Roszak, Mirosława Gałęcka, Wojciech Cichy, Patrycja Szachta. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases. Advances in Medical Sciences 2015; 60(2): 246 doi: 10.1016/j.advms.2015.04.003
|
46 |
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. The Mexican consensus on irritable bowel syndrome. Revista de Gastroenterología de México (English Edition) 2016; 81(3): 149 doi: 10.1016/j.rgmxen.2016.01.004
|
47 |
Antonio Carroccio, Aurelio Seidita, Alberto D’Alcamo, Pasquale Mansueto. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World Journal of Gastroenterology 2015; 21(23): 7089-7109 doi: 10.3748/wjg.v21.i23.7089
|
48 |
Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, Gianpiero Stefanelli, Marco Valvano, Giovanni Latella. Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?. Digestion 2021; 102(6): 833 doi: 10.1159/000518419
|
49 |
Ulf Helwig. Pflege bei chronisch-entzündlichen Darmerkrankungen. 2023; : 79 doi: 10.1007/978-3-662-64938-1_7
|
50 |
Cristina Romero-Mascarell, Gloria Fernández-Esparrach, Cristina Rodríguez-De Miguel, Maria Carme Masamunt, Sonia Rodríguez, Jordi Rimola, Miguel Urpí, Gherzon Simon Casanova, Ingrid Ordás, Elena Ricart, Berta Caballol, Agnès Fernández-Clotet, Julià Panés, Josep Llach, Begoña González-Suárez. Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?. Diagnostics 2022; 12(9): 2226 doi: 10.3390/diagnostics12092226
|